GSK gets EC approval for new administration options of asthma treatment Nucala

GlaxoSmithKline (GSK) has secured marketing authorisation from the European Commission (EC) for two new administration options of Nucala (mepolizumab) to treat patients with severe eosinophilic asthma. Nucala, a pre-filled pen and a pre-filled safety syringe, is claimed to be the only monthly anti-IL5 biologic approved in Europe to treat patients with severe eosinophilic asthma at

Read More


Some health websites are notoriously misleading: their reliability rated

Source STAT For millions of Americans, including health professionals, the resurgence of measles is a confounding and frightening development. How can a disease declared eliminated nearly two decades ago come back when it can be prevented with a vaccine proven to be safe and effective? But that’s not the reality for those getting their health information from

Read More


A New Liquid Biopsy Chip Developed at Worcester Polytechnic institute Detects Circulating Tumor Cells in 100 Percent of Blood Samples from Stage 1-4 Breast Cancer Patients

Using the tendency of circulating cancer cells to adhere to carbon nanotubes, the easily mass-produced chip captures living cells and cell clusters of multiple types and sizes with high reliability and makes them available for analysis. The chip could be used to detect tumors at the earliest stages, before they can metastasize Researchers at Worcester

Read More


The Mitochondrion as an Emerging Therapeutic Target in Cancer

Source https://www.cell.com/trends/molecular-medicine/fulltext/S1471-4914(19)30171-6 Mitochondria display a dynamic and heterogeneous phenotype that facilitates the metabolic heterogeneity and plasticity of cancer cells. The altered metabolic functions and dynamics of mitochondria in cancer cells, as well as mitochondrial evasion of apoptosis, provide targets for novel cancer therapeutics. The mitochondrial network has distinct morphological features that appear to be interrelated

Read More